Increasing Vaccine Efficacy with Novel Adjuvants

Abstract

Get full access to this article

View all access options for this article.

References

Castrodeza-Sanz

, Sanz-Muñoz

, Eiros

. Adjuvants for COVID-19 Vaccines. Vaccines (Basel) , 2023; 11(5): 902.

Zhao

, Cai

, Jiang

, et al. Vaccine adjuvants: Mechanisms and platforms. Signal Transduct. Target. Ther. , 2023; 8(1): 283.

Reed

, Orr

, Fox

. Key roles of adjuvants in modern vaccines. Nat. Med. , 2013; 19(12): 1597–1608.

Di Pasquale

, Preiss

, Tavares Da Silva

, Garçon

. Vaccine Adjuvants: From 1920 to 2015 and Beyond. Vaccines (Basel) , 2015; 3(2): 320–343.

Nanishi

, Dowling

, Levy

. Toward precision adjuvants: Optimizing science and safety. Curr. Opin. Pediatr. , 2020; 32(1): 125–138.

Baudner

, Ronconi

, Casini

, et al. MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). Pharm. Res. , 2009; 26(6): 1477–1485.

Melgar

, Britton

, Roper

, et al. Use of respiratory syncytial virus vaccines in older adults: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023. MMWR Morb. Mortal. Wkly. Rep. , 2023; 72: 793–801.

Yang

, Su

, Yao

, et al. Key Process Parameters Study for the Fill Finish of Vaccines Containing Aluminum Hydroxide Adjuvant. J. Pharm. Sci. , 2024; 113(6): 1478–1487.